These results show that Dvl2 can directly inhibit inflammatory cytokine secretion by RA-FLSs in vitro, with the effect being more pronounced when the NF-κB pathway is activated by TNF-α. The gene discussed is DVL2; the disease is rheumatoid arthritis.